in Health care
USFDA nod to Zydus Lifesciences glaucoma drug Acetazolamide
Ahmedabad: Pharma major, Zydus Lifesciences Limited, has announced that the company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Acetazolamide Tablets USP, 125 mg and 250 mg (USRLD: Diamox Tablets, 125 mg and 250 mg). Acetazolamide is used to treat glaucoma, a condition in which increased pressure […] More
